Boston, June 16–19, 2025 — At the heart of one of the most influential biotech gatherings in the world, Math Biology stepped into the global spotlight at BIO International Convention at the Boston Convention & Exhibition Center.
Representing Italy’s cutting edge in AI-driven health innovation, Math Biology was selected to showcase DMA® (Deep Metabolic-Processes Assessment) — a first-of-its-kind, zero-invasive screening method that’s redefining how we approach early diagnosis and personalized treatment.
What We Brought to Boston
BIO 2025 wasn’t just another conference — it was a living lab of future healthcare. Math Biology stood out with:
- A live presence at the Italian Pavilion, powered by Innovit
- Private meetings with global pharma, VCs, and health tech accelerators
- Conversations on translational science, personalized health, and scaling precision diagnostics
- A compelling vision: a new health paradigm grounded in math, biology, and AI
“Walking into BIO with DMA® was like showing tomorrow’s diagnostics today,”
— said Raffaele Maccioni, Co-Founder & CTO.
“We’re not offering just a test. We’re offering a companion for lifelong health.”
Why It Mattered
As health systems worldwide pivot toward prevention, personalization, and data intelligence, Math Biology brought an answer shaped by years of cross-disciplinary research:
a way to see illness before it manifests, using AI to decode invisible metabolic signals.
For a company born out of deep Italian research, BIO Boston was not only a stage — it was a launchpad.
Looking Ahead
From Boston to the world, Math Biology is building a new culture of health — one where diagnostics become dynamic, continuous, and centered on the individual.
And BIO 2025 confirmed what we already knew:
The world is ready.